1,832
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Prenatal diagnosis of 15q11.2 microdeletion fetuses in Eastern China: 21 case series and literature review

, , , , , & show all
Article: 2262700 | Received 11 Jul 2022, Accepted 19 Sep 2023, Published online: 28 Sep 2023

References

  • Nicholls RD, Knoll JH, Butler MG, et al. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature. 1989;342(6247):281–285. doi:10.1038/342281a0.
  • Williams CA, Driscoll DJ, Dagli AI. Clinical and genetic aspects of angelman syndrome. Genet Med. 2010;12(7):385–395. doi:10.1097/GIM.0b013e3181def138.
  • Schaaf CP, Gonzalez-Garay ML, Xia F, et al. Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Nat Genet. 2013;45(11):1405–1408. doi:10.1038/ng.2776.
  • Butler MG. Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder. J Intellect Disabil Res. 2017;61(6):568–579. doi:10.1111/jir.12382.
  • Kalsner L, Chamberlain SJ. Prader-Willi, angelman, and 15q11-q13 duplication syndromes. Pediatr Clin North Am. 2015;62(3):587–606. doi:10.1016/j.pcl.2015.03.004.
  • Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011;130(4):517–528. doi:10.1007/s00439-011-0970-4.
  • Cox DM, Butler MG. The 15q11.2 BP1-BP2 microdeletion syndrome: a review. Int J Mol Sci. 2015;16(2):4068–4082. doi:10.3390/ijms16024068.
  • Rosenfeld JA, Coe BP, Eichler EE, et al. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet Med. 2013;15(6):478–481. doi:10.1038/gim.2012.164.
  • Butler MG, Bittel DC, Kibiryeva N, et al. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics. 2004;113(3 Pt 1):565–573. doi:10.1542/peds.113.3.565.
  • Kang J, Lee CN, Su YN, et al. The prenatal diagnosis and clinical outcomes of fetuses with 15q11.2 copy number variants: a case series of 36 patients. Front Med (Lausanne). 2021;8:754521. doi:10.3389/fmed.2021.754521.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097.
  • Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10: ED000142.
  • Maya I, Perlman S, Shohat M, et al. Should We report 15q11.2 BP1-BP2 deletions and duplications in the prenatal setting? J Clin Med. 2020;9(8):2602. doi:10.3390/jcm9082602.
  • Huang X, Chen J, Hu W, et al. A report on seven fetal cases associated with 15q11-q13 microdeletion and microduplication. Mol Genet Genomic Med. 2021;9(3):e1605.
  • Chen CP, Chang SY, Wang LK, et al. Prenatal diagnosis of a familial 15q11.2 (BP1-BP2) microdeletion encompassing TUBGCP5, CYFIP1, NIPA2 and NIPA1 in a fetus with ventriculomegaly, microcephaly and intrauterine growth restriction on prenatal ultrasound. Taiwan J Obstet Gynecol. 2018;57(5):730–733. doi:10.1016/j.tjog.2018.08.022.
  • Barone C, Novelli A, Bianca I, et al. 15q11.2 microdeletion and hypoplastic left heart syndrome. Eur J Med Genet. 2015;58(11):608–610. doi:10.1016/j.ejmg.2015.09.012.
  • Vanlerberghe C, Petit F, Malan V, et al. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients. Eur J Med Genet. 2015;58(3):140–147. doi:10.1016/j.ejmg.2015.01.002.
  • Magri C, Sacchetti E, Traversa M, et al. New copy number variations in schizophrenia. PLoS One. 2010;5(10):e13422. doi:10.1371/journal.pone.0013422.
  • Grozeva D, Conrad DF, Barnes CP, et al. Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr Res. 2012;135(1-3):1–7. doi:10.1016/j.schres.2011.11.004.
  • Rees E, Walters JT, Georgieva L, et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry. 2014;204(2):108–114. doi:10.1192/bjp.bp.113.131052.
  • Kirov G, Grozeva D, Norton N, et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 2009;18(8):1497–1503. doi:10.1093/hmg/ddp043.
  • Ikeda M, Aleksic B, Kirov G, et al. Copy number variation in schizophrenia in the japanese population. Biol Psychiatry. 2010;67(3):283–286. doi:10.1016/j.biopsych.2009.08.034.
  • Kirov G, Rees E, Walters JT, et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry. 2014;75(5):378–385. doi:10.1016/j.biopsych.2013.07.022.
  • Marshall CR, Howrigan DP, Merico D, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017;49(1):27–35. doi:10.1038/ng.3725.
  • Zhao Q, Li T, Zhao X, et al. Rare CNVs and tag SNPs at 15q11.2 are associated with schizophrenia in the han chinese population. Schizophr Bull. 2013;39(3):712–719. doi:10.1093/schbul/sbr197.
  • Rudd DS, Axelsen M, Epping EA, et al. A genome-wide CNV analysis of schizophrenia reveals a potential role for a multiple-hit model. Am J Med Genet B Neuropsychiatr Genet. 2014;165B(8):619–626. doi:10.1002/ajmg.b.32266.
  • Saxena S, Kkani P, Ramasubramanian C, et al. Analysis of 15q11.2 CNVs in an indian population with schizophrenia. Ann Hum Genet. 2019;83(3):187–191. doi:10.1111/ahg.12300.
  • Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455(7210):232–236. doi:10.1038/nature07229.
  • Li Z, Chen J, Xu Y, et al. Genome-wide analysis of the role of copy number variation in schizophrenia risk in chinese. Biol Psychiatry. 2016;80(4):331–337. doi:10.1016/j.biopsych.2015.11.012.
  • de Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 2010;133(Pt 1):23–32. doi:10.1093/brain/awp262.
  • Mefford HC, Muhle H, Ostertag P, et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet. 2010;6(5):e1000962. doi:10.1371/journal.pgen.1000962.
  • Mullen SA, Carvill GL, Bellows S, et al. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology. 2013;81(17):1507–1514. doi:10.1212/WNL.0b013e3182a95829.
  • Jiang Y, Zhang Y, Zhang P, et al. NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsy. Hum Genet. 2012;131(7):1217–1224. doi:10.1007/s00439-012-1149-3.
  • Chaste P, Sanders SI, Mohan KN, et al. Modest impacion risk for autism spectrum disorder of rare copy number variants at 15q11.2,specifically breakpoints 1 to 2. Autism Res. 2014;7(3):355–362. doi:10.1002/aur.1378.
  • Kommu N, Sanders S, Kaminsky E, et al. Analysis of CNVs of the BP1-BP2 region(15q11.2) suggests mild pathogenicity in autism families. Ame Soc Hum Genetics/ICHG. 2011;1019T.
  • Leblond CS, Heinrich J, Delorme R, et al. Genetic and functional analyses of SHANK2 mutationssuggest a multiple hit model of autism spectrum disorders[J]. PLoS Genet. 2012;8(2):e1002521. doi:10.1371/journal.pgen.1002521.
  • De Wolf V, Brison N, Devriendt K, et al. Genetic counseling for susceptibility loci and neurodevelopmental disorders: the del15q11.2 as an example. Am J Med Genet A. 2013;161A(11):2846–2854. doi:10.1002/ajmg.a.36209.
  • Goytain A, Hines RM, El-Husseini A, et al. NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem. 2007;282(11):8060–8068. doi:10.1074/jbc.M610314200.
  • Pathania M, Davenport EC, Muir J, et al. The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines. Transl Psychiatry. 2014;4(3):e374–e374. doi:10.1038/tp.2014.16.
  • Cafferkey M, Ahn JW, Flinter F, et al. Phenotypic features in patients with 15q11.2(BP1-BP2) deletion: further delineation of an emerging syndrome. Am J Med Genet A. 2014;164A(8):1916–1922. doi:10.1002/ajmg.a.36554.